Chemomab Therapeutics(CMMB) - 2022 Q2 - Earnings Call Transcript

Call Start: 08:00 January 1, 0000 8:42 AM ET Chemomab Therapeutics Ltd. (NASDAQ:CMMB) Q2 2022 Earnings Conference Call August 12, 2022 08:00 ET CompanyParticipants Barbara Lindheim - Consulting Vice President Investor & Public Relations Dale Pfost - Chairman & Chief Executive Officer David Weiner - Interim Chief Medical Officer Don Marvin - Chief Financial Officer & Chief Operating Officer Conference Call Participants Jeff Jones - Oppenheimer Kristen Kluska - Cantor Fitzgerald Nathan Weinstein - Aegis Capit ...